Exhibit 23.2
INDEPENDENT AUDITORS CONSENT
We consent to the use of our report incorporated by reference in the
Registration Statement (Form S-8) pertaining to the Access Pharmaceuticals,
Inc. 1995 Stock Option Plan.
Our report dated March 24, 1998 contains an explanatory paragraph that states
that the Company has suffered recurring losses from operations and has a net
capital deficiency, which raise substantial doubt about its ability to
continue as a going concern. The consolidated financial statements do not
include any adjustments that might result from the outcome of that
uncertainty.
/s/ KPMG LLP
KPMG LLP
Dallas, Texas
September 8, 2000
